Mistry PK - Search Results

1

The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease.

Drelichman G, Castañeda-Hernández G, Cem Ar M, Dragosky M, Garcia R, Lee H, Moiseev S, Naderi M, Rosenbaum H, Žnidar I, Zuluaga AF, Freisens S, Mistry PK. Drelichman G, et al. Among authors: mistry pk. Am J Hematol. 2020 Mar;95(3):233-237. doi: 10.1002/ajh.25701. Epub 2019 Dec 23. Am J Hematol. 2020. PMID: 31816110 Free PMC article. Review. No abstract available.

2

Guidance on the use of miglustat for treating patients with type 1 Gaucher disease.

Weinreb NJ, Barranger JA, Charrow J, Grabowski GA, Mankin HJ, Mistry P. Weinreb NJ, et al. Am J Hematol. 2005 Nov;80(3):223-9. doi: 10.1002/ajh.20504. Am J Hematol. 2005. PMID: 16247743 Free article. Review.

3

Therapeutic goals in Gaucher disease.

Mistry P, Germain DP. Mistry P, et al. Rev Med Interne. 2006 Mar;27 Suppl 1:S30-8. doi: 10.1016/s0248-8663(06)80009-3. Rev Med Interne. 2006. PMID: 16644400 English, French.

4

Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention.

Mistry PK, Sadan S, Yang R, Yee J, Yang M. Mistry PK, et al. Am J Hematol. 2007 Aug;82(8):697-701. doi: 10.1002/ajh.20908. Am J Hematol. 2007. PMID: 17492645 Free article.

5

Life expectancy in Gaucher disease type 1.

Weinreb NJ, Deegan P, Kacena KA, Mistry P, Pastores GM, Velentgas P, vom Dahl S. Weinreb NJ, et al. Am J Hematol. 2008 Dec;83(12):896-900. doi: 10.1002/ajh.21305. Am J Hematol. 2008. PMID: 18980271 Free PMC article.

6

The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients.

Taddei TH, Kacena KA, Yang M, Yang R, Malhotra A, Boxer M, Aleck KA, Rennert G, Pastores GM, Mistry PK. Taddei TH, et al. Among authors: mistry pk. Am J Hematol. 2009 Apr;84(4):208-14. doi: 10.1002/ajh.21362. Am J Hematol. 2009. PMID: 19260119 Free PMC article.

7

Gaucher disease: resetting the clinical and scientific agenda.

Mistry PK, Weinreb NJ, Brady RO, Grabowski GA. Mistry PK, et al. Am J Hematol. 2009 Apr;84(4):205-7. doi: 10.1002/ajh.21384. Am J Hematol. 2009. PMID: 19296473 Free PMC article. No abstract available.

8

Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype.

Lo SM, Stein P, Mullaly S, Bar M, Jain D, Pastores GM, Mistry PK. Lo SM, et al. Among authors: mistry pk. Am J Hematol. 2010 May;85(5):340-5. doi: 10.1002/ajh.21684. Am J Hematol. 2010. PMID: 20425796 Free PMC article.

9

Hyperferritinemia and iron overload in type 1 Gaucher disease.

Stein P, Yu H, Jain D, Mistry PK. Stein P, et al. Among authors: mistry pk. Am J Hematol. 2010 Jul;85(7):472-6. doi: 10.1002/ajh.21721. Am J Hematol. 2010. PMID: 20575041 Free PMC article.

10

A reappraisal of Gaucher disease-diagnosis and disease management algorithms.

Mistry PK, Cappellini MD, Lukina E, Ozsan H, Mach Pascual S, Rosenbaum H, Helena Solano M, Spigelman Z, Villarrubia J, Watman NP, Massenkeil G. Mistry PK, et al. Am J Hematol. 2011 Jan;86(1):110-5. doi: 10.1002/ajh.21888. Am J Hematol. 2011. PMID: 21080341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page